| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.28 | 2e-07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |